Serpinc1tm1(EGFP/cre/ERT2)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Serpinc1tm1(EGFP/cre/ERT2)Wtsi |
| Name: |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1; targeted mutation 1, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:7867283 |
| Gene: |
Serpinc1 Location: Chr1:160806153-160830113 bp, + strand Genetic Position: Chr1, 69.75 cM
|
| Alliance: |
Serpinc1tm1(EGFP/cre/ERT2)Wtsi page
|
|
| Mutant Cell Line: |
CEPD0064_3_B09 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:82809
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
|
| Allele Type: |
|
Targeted (Conditional ready, Inducible, Null/knockout, Recombinase, Reporter) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Serpinc1tm1(EGFP/cre/ERT2)Wtsi expression driven by
1 gene
Knock-in expression driven by:
| Organism |
Driver Gene |
Note |
| mouse |
Serpinc1 (MGI:88095) |
|
|
| |
|
Mutation details: The following elements were inserted into intron 2: FRT site, En2 splice acceptor sequence, sequence coding for F2A self-cleaving peptide, EGFP reporter gene, sequence coding for T2A self-cleaving peptide, cre/ERT2 inducible recombinase gene, SV40 poly(A) signal sequence, Rox site flanked puromycin resistance gene cassette, and a loxP site. A second loxP site was inserted into intron 3. This creates a reporter-recombinase knockout allele with a floxed exon 3.
(J:82809)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Serpinc1
(mouse)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Serpinc1 Mutation: |
28 strains or lines available
|
|
| Original: |
J:82809 European Mouse Mutant Archive, Information obtained from the European Mouse Mutant Archive (EMMA). Unpublished. 2003-2013; |
| All: |
1 reference(s) |
|
Analysis Tools
